D
PharmaCorp Rx Inc. PCRX.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 34.20% 217.98% 441.35% -849.60% -747.08%
Total Depreciation and Amortization 731.10% -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -333.33% -- -- -- --
Change in Net Operating Assets -92.66% -2,175.51% 1,103.14% -2,516.55% 2,190.28%
Cash from Operations -17.39% 164.32% 473.63% -676.61% -74.51%
Capital Expenditure -30,524.00% -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -1,356.83% -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -4,330.78% -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -230.07% -- -- -- --
Issuance of Common Stock -- -- -- -- 254,457.69%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -100.25% -- -- -- 249,887.93%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -116.89% 125.78% -4,522.81% 5,979.90% 24,163.00%